Skip to contentI
Innoviva, Inc.
I
INVAInnoviva, Inc. Q2 2013 · 10-Q
Revenue$1.32M$1.32M−7.6% vs Q2 2012 Net income—
EPS Diluted-$0.37-$0.37N/M vs Q2 2012 Operating Income-$41,786,000N/M Operating Cash Flowderived-$16,686,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
Free Cash Flowderived-$17,377,000N/M Margins · derivedOperating margin-3160.8%−663.7 pt vs Q2 2012
ended Jun 30, 2013 · filed Aug 1, 2013 · 32 d after period end